How Tilray-MedMen deal could impact either cannabis company’s US aspirations

Last week, British Columbia-based Tilray (TLRY on Nasdaq, TSX), the second-largest Canadian licensed producer by market cap, announced a transaction to gain a substantial interest in U.S. cannabis retailer MedMen.

How Tilray-MedMen deal could impact either cannabis company’s US aspirations is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs